oncology insights Oncology Insights: 2024 Rewind January 16, 2025 Last year, Oncology Insights brought you the most talked about topics in 2024. As we enter this new year, let us review these...

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Perspectives High-Cost Therapy Profile: June 2024 Detailed information about Imetelstat Intravenous (IV) June 14, 2024 High Cost Therapy Profile Oncology Imetelstat Intravenous (IV) Geron Proposed...

publications 2024 Employer Market Insights Report June 28, 2024 Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication,...

Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...

Event features Pat Gleason, AVP, health outcomes at Prime Therapeutics

Cover image for FDA Decisions Expected November 2024 Drug pipeline for November 2024 Prime Therapeutics /fda-decisions-expected-november-2024 Prime Therapeutics’ FDA Decisions Expected outlines...

publications High-Cost Therapy Profile: February 2025 Revakinagene taroretcel Ocular implant | Neurotech Pharmaceuticals, Inc. Ophthalmology February 13, 2025 Proposed indications Macular...

See our award-winning people & work Prime delivers unmatched care, groundbreaking research and industry-leading programs and services for health plans, employers and members. Breadcrumb Home Who we...